PHASE II TRIAL OF IMMUNOTHERAPY IN PRIMARY GLIOBLASTOMA: ANTIGENS FROM SELF-RENEWING AUTOLOGOUS TUMOR CELLS PRESENTED BY AUTOLOGOUS DENDRITIC CELL VACCINE

Authors
Category Primary study
JournalJOURNAL FOR IMMUNOTHERAPY OF CANCER
Year 2020
This article has no abstract
Epistemonikos ID: 72fd6e56ff9e373f8790085bf72f17a0c1276648
First added on: Feb 12, 2025